Cargando…
Soluble Epoxide Hydrolase Inhibition in Liver Diseases: A Review of Current Research and Knowledge Gaps
Emerging evidence suggests that soluble epoxide hydrolase (sEH) inhibition is a valuable therapeutic strategy for the treatment of numerous diseases, including those of the liver. sEH rapidly degrades cytochrome P450-produced epoxygenated lipids (epoxy-fatty acids), which are synthesized from omega-...
Autores principales: | Warner, Jeffrey, Hardesty, Josiah, Zirnheld, Kara, McClain, Craig, Warner, Dennis, Kirpich, Irina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345757/ https://www.ncbi.nlm.nih.gov/pubmed/32545637 http://dx.doi.org/10.3390/biology9060124 |
Ejemplares similares
-
Linoleic Acid‐Derived Oxylipins Differentiate Early Stage Alcoholic Hepatitis From Mild Alcohol‐Associated Liver Injury
por: Warner, Dennis, et al.
Publicado: (2021) -
Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease
por: Warner, Jeffrey Barr, et al.
Publicado: (2022) -
Fpr2(−/−) Mice Developed Exacerbated Alcohol-Associated Liver Disease
por: Hardesty, Josiah E., et al.
Publicado: (2023) -
Fat-1 Transgenic Mice With Augmented n3-Polyunsaturated Fatty Acids Are Protected From Liver Injury Caused by Acute-On-Chronic Ethanol Administration
por: Warner, Jeffrey, et al.
Publicado: (2021) -
Ileum Gene Expression in Response to Acute Systemic Inflammation in Mice Chronically Fed Ethanol: Beneficial Effects of Elevated Tissue n-3 PUFAs
por: Hardesty, Josiah E., et al.
Publicado: (2021)